Asahi Intecc KK header image

Asahi Intecc KK

7747

Equity

ISIN JP3110650003 / Valor 1872022

Tokyo Stock Exchange (2024-09-18)
JPY 2,599.00+0.12%

Asahi Intecc KK
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Asahi Intecc KK is a Japanese company specializing in the development, manufacturing, and sale of medical devices and components, particularly guidewires and catheters used in minimally invasive procedures.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (14.08.2024):

Net Sales Growth

Asahi Intecc KK reported net sales of 80,733 million yen for the nine months ended March 31, 2024, marking a 15.7% increase year-on-year. This growth was primarily driven by a significant rise in overseas net sales, attributed to the recovery and expansion of the market following the diminished impact of COVID-19, favorable exchange rates, and increased market demand.

Operating Profit Increase

For the nine months ended March 31, 2024, Asahi Intecc KK achieved an operating profit of 19,656 million yen, reflecting a 19.7% year-on-year increase. This improvement occurred despite higher selling, general, and administrative expenses, which included increased sales promotion costs in overseas markets and higher R&D expenses.

Profit Attributable to Owners

Asahi Intecc KK reported a profit attributable to owners of the parent company amounting to 14,040 million yen for the nine months ended March 31, 2024. This represents a 17.2% increase compared to the same period in the previous year, underscoring the company's strong financial performance during this period.

Equity-to-Asset Ratio

As of March 31, 2024, Asahi Intecc KK's equity-to-asset ratio stood at 81.0%, up from 76.6% as of June 30, 2023. This improvement indicates a stronger financial position and a higher proportion of equity financing relative to total assets.

Dividend Forecast

Asahi Intecc KK has forecasted an annual dividend of 16.43 yen per share for the fiscal year ending June 30, 2024. This represents an increase from the 14.48 yen per share dividend paid in the previous fiscal year, reflecting the company's confidence in its ongoing financial stability and growth prospects.

Summarized from source with an LLMView Source

Key figures

-12.5%1Y
-20.9%3Y
-3.02%5Y

Performance

35.3%1Y
39.1%3Y
36.6%5Y

Volatility

Market cap

5000 M

Market cap (USD)

Daily traded volume (Shares)

814,200

Daily traded volume (Shares)

1 day high/low

2647 / 2580

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Ultragenyx Pharmaceutical Inc
Ultragenyx Pharmaceutical Inc Ultragenyx Pharmaceutical Inc Valor: 22860122
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.35%USD 57.70
Agenus Inc
Agenus Inc Agenus Inc Valor: 134326284
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.89%USD 6.05
EssilorLuxottica SA
EssilorLuxottica SA EssilorLuxottica SA Valor: 497537
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.34%EUR 204.80
Eurofins Scientific SE
Eurofins Scientific SE Eurofins Scientific SE Valor: 58317129
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.91%EUR 52.34
Dermapharm Holding SE
Dermapharm Holding SE Dermapharm Holding SE Valor: 40166352
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.43%EUR 35.10
Formycon AG
Formycon AG Formycon AG Valor: 12194189
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.10%EUR 49.35
Maternus-Kliniken AG
Maternus-Kliniken AG Maternus-Kliniken AG Valor: 335800
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.35%EUR 1.74
Vitrolife AB
Vitrolife AB Vitrolife AB Valor: 41707777
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.18%SEK 237.80
Elekta AB
Elekta AB Elekta AB Valor: 613625
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.88%SEK 68.70
BioArctic AB
BioArctic AB BioArctic AB Valor: 38514501
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.59%SEK 170.30